Industry Research Reports
Home > Reports > Service & Software > Global Pharmaceutical Analytical Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Pharmaceutical Analytical Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-11-16
Pages: 137 Pages
Report ld: 5475777
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Pharmaceutical Analytical Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Pharmaceutical Analytical Testing refers to the scientific process of evaluating pharmaceutical products and raw materials to ensure their quality, safety, and efficacy. It involves a range of tests and techniques that measure and analyze the chemical composition, physical properties, and biological activity of pharmaceutical substances. These tests are conducted in compliance with regulatory standards to verify the identity, purity, strength, and stability of drugs and ensure they meet the required specifications before being released to the market. Pharmaceutical analytical testing plays a crucial role in maintaining the integrity and effectiveness of pharmaceutical products throughout their lifecycle.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Pharmaceutical Analytical Testing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Laboratory Testing
- Eurofins Scientific
- SGS SA
- Intertek Phamaceutical Services
- West Pharmaceutical Services
- Toxikon
- Pace Analytical Services
- Boston Analytical
- Steris
- Catalent
- Charles River Laboratories
- Merck
- Solvias
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Bioanalytical Testing
- Method Development & Validation
- Stability Testing
- Drug Substances Testing
Segment by Application
- Laboratory and Research Institutions
- Pharmaceutical Center
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Pharmaceutical Analytical Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pharmaceutical Analytical Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Analytical Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Bioanalytical Testing
1.2.3 Method Development & Validation
1.2.4 Stability Testing
1.2.5 Drug Substances Testing
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Analytical Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Laboratory and Research Institutions
1.3.3 Pharmaceutical Center
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Analytical Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Analytical Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pharmaceutical Analytical Testing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pharmaceutical Analytical Testing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Bioanalytical Testing Market Size by Players
3.3.2 Method Development & Validation Market Size by Players
3.3.3 Stability Testing Market Size by Players
3.3.4 Drug Substances Testing Market Size by Players
3.4 Global Pharmaceutical Analytical Testing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceutical Analytical Testing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceutical Analytical Testing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pharmaceutical Analytical Testing Market Size by Type (2020-2031)
6.4 North America Pharmaceutical Analytical Testing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceutical Analytical Testing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pharmaceutical Analytical Testing Market Size by Type (2020-2031)
7.4 Europe Pharmaceutical Analytical Testing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceutical Analytical Testing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pharmaceutical Analytical Testing Market Size by Type (2020-2031)
8.4 Asia-Pacific Pharmaceutical Analytical Testing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pharmaceutical Analytical Testing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pharmaceutical Analytical Testing Market Size by Type (2020-2031)
9.4 Central and South America Pharmaceutical Analytical Testing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceutical Analytical Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pharmaceutical Analytical Testing Market Size by Type (2020-2031)
10.4 Middle East and Africa Pharmaceutical Analytical Testing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceutical Analytical Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Laboratory Testing
11.1.1 Laboratory Testing Corporation Information
11.1.2 Laboratory Testing Business Overview
11.1.3 Laboratory Testing Pharmaceutical Analytical Testing Product Features and Attributes
11.1.4 Laboratory Testing Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.1.5 Laboratory Testing Pharmaceutical Analytical Testing Revenue by Product in 2024
11.1.6 Laboratory Testing Pharmaceutical Analytical Testing Revenue by Application in 2024
11.1.7 Laboratory Testing Pharmaceutical Analytical Testing Revenue by Geographic Area in 2024
11.1.8 Laboratory Testing Pharmaceutical Analytical Testing SWOT Analysis
11.1.9 Laboratory Testing Recent Developments
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Corporation Information
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Pharmaceutical Analytical Testing Product Features and Attributes
11.2.4 Eurofins Scientific Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.2.5 Eurofins Scientific Pharmaceutical Analytical Testing Revenue by Product in 2024
11.2.6 Eurofins Scientific Pharmaceutical Analytical Testing Revenue by Application in 2024
11.2.7 Eurofins Scientific Pharmaceutical Analytical Testing Revenue by Geographic Area in 2024
11.2.8 Eurofins Scientific Pharmaceutical Analytical Testing SWOT Analysis
11.2.9 Eurofins Scientific Recent Developments
11.3 SGS SA
11.3.1 SGS SA Corporation Information
11.3.2 SGS SA Business Overview
11.3.3 SGS SA Pharmaceutical Analytical Testing Product Features and Attributes
11.3.4 SGS SA Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.3.5 SGS SA Pharmaceutical Analytical Testing Revenue by Product in 2024
11.3.6 SGS SA Pharmaceutical Analytical Testing Revenue by Application in 2024
11.3.7 SGS SA Pharmaceutical Analytical Testing Revenue by Geographic Area in 2024
11.3.8 SGS SA Pharmaceutical Analytical Testing SWOT Analysis
11.3.9 SGS SA Recent Developments
11.4 Intertek Phamaceutical Services
11.4.1 Intertek Phamaceutical Services Corporation Information
11.4.2 Intertek Phamaceutical Services Business Overview
11.4.3 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Product Features and Attributes
11.4.4 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.4.5 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Revenue by Product in 2024
11.4.6 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Revenue by Application in 2024
11.4.7 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Revenue by Geographic Area in 2024
11.4.8 Intertek Phamaceutical Services Pharmaceutical Analytical Testing SWOT Analysis
11.4.9 Intertek Phamaceutical Services Recent Developments
11.5 West Pharmaceutical Services
11.5.1 West Pharmaceutical Services Corporation Information
11.5.2 West Pharmaceutical Services Business Overview
11.5.3 West Pharmaceutical Services Pharmaceutical Analytical Testing Product Features and Attributes
11.5.4 West Pharmaceutical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.5.5 West Pharmaceutical Services Pharmaceutical Analytical Testing Revenue by Product in 2024
11.5.6 West Pharmaceutical Services Pharmaceutical Analytical Testing Revenue by Application in 2024
11.5.7 West Pharmaceutical Services Pharmaceutical Analytical Testing Revenue by Geographic Area in 2024
11.5.8 West Pharmaceutical Services Pharmaceutical Analytical Testing SWOT Analysis
11.5.9 West Pharmaceutical Services Recent Developments
11.6 Toxikon
11.6.1 Toxikon Corporation Information
11.6.2 Toxikon Business Overview
11.6.3 Toxikon Pharmaceutical Analytical Testing Product Features and Attributes
11.6.4 Toxikon Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.6.5 Toxikon Recent Developments
11.7 Pace Analytical Services
11.7.1 Pace Analytical Services Corporation Information
11.7.2 Pace Analytical Services Business Overview
11.7.3 Pace Analytical Services Pharmaceutical Analytical Testing Product Features and Attributes
11.7.4 Pace Analytical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.7.5 Pace Analytical Services Recent Developments
11.8 Boston Analytical
11.8.1 Boston Analytical Corporation Information
11.8.2 Boston Analytical Business Overview
11.8.3 Boston Analytical Pharmaceutical Analytical Testing Product Features and Attributes
11.8.4 Boston Analytical Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.8.5 Boston Analytical Recent Developments
11.9 Steris
11.9.1 Steris Corporation Information
11.9.2 Steris Business Overview
11.9.3 Steris Pharmaceutical Analytical Testing Product Features and Attributes
11.9.4 Steris Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.9.5 Steris Recent Developments
11.10 Catalent
11.10.1 Catalent Corporation Information
11.10.2 Catalent Business Overview
11.10.3 Catalent Pharmaceutical Analytical Testing Product Features and Attributes
11.10.4 Catalent Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Charles River Laboratories
11.11.1 Charles River Laboratories Corporation Information
11.11.2 Charles River Laboratories Business Overview
11.11.3 Charles River Laboratories Pharmaceutical Analytical Testing Product Features and Attributes
11.11.4 Charles River Laboratories Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.11.5 Charles River Laboratories Recent Developments
11.12 Merck
11.12.1 Merck Corporation Information
11.12.2 Merck Business Overview
11.12.3 Merck Pharmaceutical Analytical Testing Product Features and Attributes
11.12.4 Merck Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.12.5 Merck Recent Developments
11.13 Solvias
11.13.1 Solvias Corporation Information
11.13.2 Solvias Business Overview
11.13.3 Solvias Pharmaceutical Analytical Testing Product Features and Attributes
11.13.4 Solvias Pharmaceutical Analytical Testing Revenue and Gross Margin (2020-2025)
11.13.5 Solvias Recent Developments
12 Pharmaceutical Analytical TestingIndustry Chain Analysis
12.1 Pharmaceutical Analytical Testing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceutical Analytical Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceutical Analytical Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmaceutical Analytical Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharmaceutical Analytical Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharmaceutical Analytical Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharmaceutical Analytical Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharmaceutical Analytical Testing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Pharmaceutical Analytical Testing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Pharmaceutical Analytical Testing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Pharmaceutical Analytical Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Analytical Testing as of 2024)
Table 11. Global Pharmaceutical Analytical Testing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Pharmaceutical Analytical Testing Companies Headquarters
Table 13. Global Pharmaceutical Analytical Testing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Pharmaceutical Analytical Testing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Pharmaceutical Analytical Testing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Pharmaceutical Analytical Testing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Pharmaceutical Analytical Testing Revenue by Application (2026-2031) & (US$ Million)
Table 21. Pharmaceutical Analytical Testing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Pharmaceutical Analytical Testing Growth Accelerators and Market Barriers
Table 25. North America Pharmaceutical Analytical Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Pharmaceutical Analytical Testing Growth Accelerators and Market Barriers
Table 27. Europe Pharmaceutical Analytical Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Pharmaceutical Analytical Testing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Pharmaceutical Analytical Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Pharmaceutical Analytical Testing Investment Opportunities and Key Challenges
Table 31. Central and South America Pharmaceutical Analytical Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Pharmaceutical Analytical Testing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Pharmaceutical Analytical Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Laboratory Testing Corporation Information
Table 35. Laboratory Testing Description and Major Businesses
Table 36. Laboratory Testing Product Features and Attributes
Table 37. Laboratory Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Laboratory Testing Revenue Proportion by Product in 2024
Table 39. Laboratory Testing Revenue Proportion by Application in 2024
Table 40. Laboratory Testing Revenue Proportion by Geographic Area in 2024
Table 41. Laboratory Testing Pharmaceutical Analytical Testing SWOT Analysis
Table 42. Laboratory Testing Recent Developments
Table 43. Eurofins Scientific Corporation Information
Table 44. Eurofins Scientific Description and Major Businesses
Table 45. Eurofins Scientific Product Features and Attributes
Table 46. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Eurofins Scientific Revenue Proportion by Product in 2024
Table 48. Eurofins Scientific Revenue Proportion by Application in 2024
Table 49. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Eurofins Scientific Pharmaceutical Analytical Testing SWOT Analysis
Table 51. Eurofins Scientific Recent Developments
Table 52. SGS SA Corporation Information
Table 53. SGS SA Description and Major Businesses
Table 54. SGS SA Product Features and Attributes
Table 55. SGS SA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. SGS SA Revenue Proportion by Product in 2024
Table 57. SGS SA Revenue Proportion by Application in 2024
Table 58. SGS SA Revenue Proportion by Geographic Area in 2024
Table 59. SGS SA Pharmaceutical Analytical Testing SWOT Analysis
Table 60. SGS SA Recent Developments
Table 61. Intertek Phamaceutical Services Corporation Information
Table 62. Intertek Phamaceutical Services Description and Major Businesses
Table 63. Intertek Phamaceutical Services Product Features and Attributes
Table 64. Intertek Phamaceutical Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Intertek Phamaceutical Services Revenue Proportion by Product in 2024
Table 66. Intertek Phamaceutical Services Revenue Proportion by Application in 2024
Table 67. Intertek Phamaceutical Services Revenue Proportion by Geographic Area in 2024
Table 68. Intertek Phamaceutical Services Pharmaceutical Analytical Testing SWOT Analysis
Table 69. Intertek Phamaceutical Services Recent Developments
Table 70. West Pharmaceutical Services Corporation Information
Table 71. West Pharmaceutical Services Description and Major Businesses
Table 72. West Pharmaceutical Services Product Features and Attributes
Table 73. West Pharmaceutical Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. West Pharmaceutical Services Revenue Proportion by Product in 2024
Table 75. West Pharmaceutical Services Revenue Proportion by Application in 2024
Table 76. West Pharmaceutical Services Revenue Proportion by Geographic Area in 2024
Table 77. West Pharmaceutical Services Pharmaceutical Analytical Testing SWOT Analysis
Table 78. West Pharmaceutical Services Recent Developments
Table 79. Toxikon Corporation Information
Table 80. Toxikon Description and Major Businesses
Table 81. Toxikon Product Features and Attributes
Table 82. Toxikon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Toxikon Recent Developments
Table 84. Pace Analytical Services Corporation Information
Table 85. Pace Analytical Services Description and Major Businesses
Table 86. Pace Analytical Services Product Features and Attributes
Table 87. Pace Analytical Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Pace Analytical Services Recent Developments
Table 89. Boston Analytical Corporation Information
Table 90. Boston Analytical Description and Major Businesses
Table 91. Boston Analytical Product Features and Attributes
Table 92. Boston Analytical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Boston Analytical Recent Developments
Table 94. Steris Corporation Information
Table 95. Steris Description and Major Businesses
Table 96. Steris Product Features and Attributes
Table 97. Steris Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Steris Recent Developments
Table 99. Catalent Corporation Information
Table 100. Catalent Description and Major Businesses
Table 101. Catalent Product Features and Attributes
Table 102. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Catalent Recent Developments
Table 104. Charles River Laboratories Corporation Information
Table 105. Charles River Laboratories Description and Major Businesses
Table 106. Charles River Laboratories Product Features and Attributes
Table 107. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Charles River Laboratories Recent Developments
Table 109. Merck Corporation Information
Table 110. Merck Description and Major Businesses
Table 111. Merck Product Features and Attributes
Table 112. Merck Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Merck Recent Developments
Table 114. Solvias Corporation Information
Table 115. Solvias Description and Major Businesses
Table 116. Solvias Product Features and Attributes
Table 117. Solvias Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Solvias Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Analytical Testing Product Picture
Figure 2. Global Pharmaceutical Analytical Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Bioanalytical Testing Product Picture
Figure 4. Method Development & Validation Product Picture
Figure 5. Stability Testing Product Picture
Figure 6. Drug Substances Testing Product Picture
Figure 7. Global Pharmaceutical Analytical Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Laboratory and Research Institutions
Figure 9. Pharmaceutical Center
Figure 10. Other
Figure 11. Pharmaceutical Analytical Testing Report Years Considered
Figure 12. Global Pharmaceutical Analytical Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 14. Global Pharmaceutical Analytical Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Pharmaceutical Analytical Testing Revenue Market Share by Region (2020-2031)
Figure 16. Global Pharmaceutical Analytical Testing Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Bioanalytical Testing Revenue Market Share by Player in 2024
Figure 19. Method Development & Validation Revenue Market Share by Player in 2024
Figure 20. Stability Testing Revenue Market Share by Player in 2024
Figure 21. Drug Substances Testing Revenue Market Share by Player in 2024
Figure 22. Global Pharmaceutical Analytical Testing Revenue Market Share by Type (2020-2031)
Figure 23. Global Pharmaceutical Analytical Testing Revenue Market Share by Application (2020-2031)
Figure 24. North America Pharmaceutical Analytical Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Pharmaceutical Analytical Testing Revenue (US$ Million) in 2024
Figure 26. North America Pharmaceutical Analytical Testing Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Pharmaceutical Analytical Testing Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Pharmaceutical Analytical Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Pharmaceutical Analytical Testing Revenue (US$ Million) in 2024
Figure 33. Europe Pharmaceutical Analytical Testing Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Pharmaceutical Analytical Testing Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 36. France Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Pharmaceutical Analytical Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Pharmaceutical Analytical Testing Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Pharmaceutical Analytical Testing Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Pharmaceutical Analytical Testing Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 48. India Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Pharmaceutical Analytical Testing Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Pharmaceutical Analytical Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Pharmaceutical Analytical Testing Revenue (US$ Million) in 2024
Figure 56. Central and South America Pharmaceutical Analytical Testing Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Pharmaceutical Analytical Testing Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Pharmaceutical Analytical Testing Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Pharmaceutical Analytical Testing Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Pharmaceutical Analytical Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Pharmaceutical Analytical Testing Revenue (US$ Million) in 2024
Figure 62. South America Pharmaceutical Analytical Testing Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Pharmaceutical Analytical Testing Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Pharmaceutical Analytical Testing Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Pharmaceutical Analytical Testing Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Pharmaceutical Analytical Testing Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Pharmaceutical Analytical Testing Revenue (2020-2025) & (US$ Million)
Figure 68. Pharmaceutical Analytical Testing Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pharmaceutical Analytical Testing market?
The top companies in the global Pharmaceutical Analytical Testing market are Laboratory Testing、Eurofins Scientific、SGS SA.
Related Reports
Pharmaceutical Analytical Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Analytical Testing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 119
USD 3950.00
(Single User License)
Global Pharmaceutical Analytical Testing Market Research Report 2026
The global Pharmaceutical Analytical Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-19
Pages: 119
USD 2900.00
(Single User License)
Global Pharmaceutical Analytical Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Analytical Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-17
Pages: 98
USD 4250.00
(Single User License)
Global Pharmaceutical Analytical Testing Market Research Report 2025
The global market for Pharmaceutical Analytical Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-04
Pages: 85
USD 2900.00
(Single User License)
Pharmaceutical Analytical Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Analytical Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-04
Pages: 115
USD 3950.00
(Single User License)
Global Pharmaceutical Analytical Testing Market Research Report 2024
The global Pharmaceutical Analytical Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-21
Pages: 85
USD 2900.00
(Single User License)
Pharmaceutical Analytical Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Analytical Testing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 119
USD 3950.00 (Single User License)Global Pharmaceutical Analytical Testing Market Research Report 2026
The global Pharmaceutical Analytical Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-19
Pages: 119
USD 2900.00 (Single User License)Global Pharmaceutical Analytical Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Analytical Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-17
Pages: 98
USD 4250.00 (Single User License)Global Pharmaceutical Analytical Testing Market Research Report 2025
The global market for Pharmaceutical Analytical Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-04
Pages: 85
USD 2900.00 (Single User License)Pharmaceutical Analytical Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Analytical Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-04
Pages: 115
USD 3950.00 (Single User License)Global Pharmaceutical Analytical Testing Market Research Report 2024
The global Pharmaceutical Analytical Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-21
Pages: 85
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now